Category: Covid-19 Vaccine

Page 347«..1020..346347348349..360370..»

Here’s why vaccine-hesitant Utahns say they’re avoiding the COVID-19 shot – Salt Lake Tribune

September 27, 2021

Roughly half of all Utahns who are hesitating to get their COVID-19 vaccine are worried about side effects from the shot, according to new survey estimates from the U.S. Census Bureau.

The concern ranks as the most commonplace reason for vaccine hesitancy in the Beehive State, but the survey suggests that wait-and-see attitudes and disbelief that the shot is necessary are also holding many people back.

The survey shows that the answers people give shift as their resistance hardens and begin to center on distrust of the vaccine and of the officials promoting it as a lifesaving public health measure. The data comes from the bureaus biweekly Household Pulse Survey and covers the first two weeks of September.

Carrie Butler, executive director of the Utah Public Health Association, says shes encouraged that it seems more people are uncertain about the vaccine than are firmly entrenched in opposition to it.

Some people are movable, she said, adding that vaccine efforts arent advanced by alienating people and calling them conspiracy theorists or telling them that theyre part of a far-right movement to destroy the country.

Those things are not helping them make better decisions. Theyre just backing people into their corners, she said. And the more we can provide good information and help people feel heard and understood about why theyre not getting the vaccine and then addressing those concerns, I believe that well start to see better outcomes.

(Christopher Cherrington | The Salt Lake Tribune)

That can be difficult, she said, when the attention is on the most strident vaccine skeptics. Just last week, she noted, a crowd opposed to vaccine mandates packed a Utah legislative hearing and jeered at lawmakers who challenged their assertions.

But digging deeper shows that different motivations and demographic characteristics separate the vaccine-hesitant and vaccine-resistant populations, said Ashley Kirzinger, associate director of public opinion and survey research for the Kaiser Family Foundation.

The hesitant individuals are more likely to be racial and ethnic minorities and are predominantly concerned about side effects and the safety of the vaccine, she said. That group has been shrinking as people grow more comfortable with getting inoculated.

On the other hand, theres been little movement within the vaccine-resistant population, which is disproportionately made up of white, evangelical Republicans, Kirzinger explained.

Their views of the vaccine are not really about the concerns about the safety or the side effects, she said. Throughout the pandemic, they have been less worried about getting sick from the virus. They were more likely to say the pandemic has been exaggerated. And in our data, we find that they think that the vaccine poses a greater risk to themselves than the virus itself.

Butler said she hopes state leaders and public health can find strategies that move both of these categories toward vaccination and ways of encouraging other precautions while people are still undecided.

In the meantime, individuals who are still weighing immunization should be wearing masks when theyre in indoor public spaces, avoiding large crowds and washing their hands frequently, she said.

If we can encourage people to do that while theyre waiting and seeing, she said, that should help us at least mitigate some of the risk that theyre incurring by not getting vaccinated.

The data also highlights the way social and economic inequities can play into vaccine hesitancy.

Compared to college graduates, people without a degree were more than twice as likely to say they wouldnt or probably wouldnt get the shot, according to the most recent national survey results. Respondents without insurance were also about twice as likely to say they were definitely or probably going to turn it down.

Stacy Stanford of the Utah Health Policy Project said that matches what her organization has seen on the ground and in state data on gaps between vaccination rates among Medicaid recipients and the rest of the population.

While 72.6% of all Utahns 12 and older have received at least one dose of the vaccine, only 46% of Medicaid recipients have, according to the Utah Department of Health.

In many cases, she said, these individuals arent entrenched in their views.

Maybe theyve seen some misinformation, they have questions, they dont feel informed. All of these things that cause hesitancy, she said. And those are really compounded by access barriers.

Park City and east Summit County, home to some of the states highest vaccination rates, are also where the biggest Medicaid disparities exist, according to a recent state report. There, people older than 12 who are on Medicaid are getting vaccinated at about half the rate of the community as a whole, according to the states data.

Stanford said there are a wide array of reasons for these discrepancies. Some people that her colleagues meet are skeptical the vaccines are free, or almost become suspicious when they hear theres no charge, she said.

The United States isnt super used to free health care, she said. So it can be hard for people to understand that no, this is truly free. You already paid for it with your tax dollars.

Many people are also worried they dont qualify because they dont have identification, she said. People who dont have sick leave or reliable child care might worry about side effects from the vaccine, and individuals who have had negative encounters with health care might also be reluctant.

You add misinformation to bad experiences, and then you add to that things like being a person of color already more likely to have those negative experiences all of that stuff compounds and builds barriers to vaccine acceptance, she said.

As childhood COVID-19 cases have climbed with the new school year, some parents are grateful for the chance to vaccinate their older kids and looking forward to when theyll be able to inoculate those younger than 12 against the virus.

However, Kirzinger notes, unvaccinated parents are unlikely to seek inoculation for their children, and even some vaccinated ones might need time to get comfortable with it.

About 60% of parents who have gotten the vaccine say their 12- to 17-year-old children are vaccinated, while only 4% of unvaccinated parents do, according to surveys conducted by the Kaiser Family Foundation.

As with adults, concern about side effects is the leading worry for Utah parents who are on the fence or opposed to giving their eligible children the shot, but its closely followed by lack of trust in government, according to the most recent Household Pulse Survey. Many others said their children arent high risk or that they dont trust the COVID-19 vaccine enough.

Butler said she sympathizes with parents concerns about the shot but didnt hesitate to take her own children to get the vaccine. And she hopes state officials and public health experts can equip other families with the information they need as they weigh these decisions.

Because its one thing for me to go and get a vaccine in my arm, but its a whole other thing for me to entrust somebody to give a vaccine to a five-year-old, she said. I think that when we talk about vaccinating the younger crowd of kids, we really, really have to know what were talking about when it comes to risk assessment ... so that they [parents] can make an accurate decision for their families.

Read the original post:

Here's why vaccine-hesitant Utahns say they're avoiding the COVID-19 shot - Salt Lake Tribune

Vaccination Status Is the New Must-Have on Your Resume – The Wall Street Journal

September 27, 2021

Job seekers are considering a new addition to their rsums: Covid-19 vaccination status.

As employers make vaccine rules for workers and some limit hiring to the vaccinated, people are starting to volunteer their vaccination status on job applications, in rsums and on their LinkedIn profiles.

See the rest here:

Vaccination Status Is the New Must-Have on Your Resume - The Wall Street Journal

U.S. Falls Far Behind Other Countries In COVID-19 Vaccination Rates – Here And Now

September 27, 2021

The U.S was a leader in the development for the COVID-19 vaccines and seemed poised to be the first in the world for vaccination rates. But now months later, the U.S. is by one count the 36th in the world for national vaccination rates.

The Atlantic's Derek Thompson explored what happened and tells us more.

See the rest here:

U.S. Falls Far Behind Other Countries In COVID-19 Vaccination Rates - Here And Now

States work hard to balance the amount of COVID-19 vaccines they keep on hand to avoid letting them go to waste – FingerLakes1.com

September 27, 2021

If you are a visitor of this website:

Please try again in a few minutes.

There is an issue between Cloudflare's cache and your origin web server. Cloudflare monitors for these errors and automatically investigates the cause. To help support the investigation, you can pull the corresponding error log from your web server and submit it our support team. Please include the Ray ID (which is at the bottom of this error page). Additional troubleshooting resources.

See the original post:

States work hard to balance the amount of COVID-19 vaccines they keep on hand to avoid letting them go to waste - FingerLakes1.com

Pregnant or breastfeeding? CDC says to get COVID-19 vaccine | The Globe – The Globe

September 27, 2021

The CDCs recommendation echoes statements in strong support of vaccinations from Sanford Health providers as well as several of the nations leading obstetric organizations. It comes at a time when many regions of the country are experiencing a surge in COVID-19 cases, hospitalizations and deaths.

This rise is driven by the highly contagious delta variant and draws attention to the potential risks involved for pregnant women who contract the virus. Expectant women run a higher risk than women who are not pregnant of severe illness and pregnancy complications from COVID-19, including possible miscarriage and stillbirth.

In short, the benefits in getting the vaccine far outweigh the theoretical risks.

This is not just part of a recommendation encouraging everyone to get the vaccine, said Albert Lyon, M.D., a specialist in obstetrics and gynecology at Sanford Worthington OB/GYN Clinic. For pregnant women, there can be significant complications with COVID that make it even more important for them to receive the vaccine.

CDC data reveals, as of July 31, that just 23% of pregnant women received at least one dose of a COVID-19 vaccine. The hope is that the updated and strengthened CDC guideline can help boost those rates.

There is a lot of misinformation out there, especially regarding vaccines and fertility, Dr. Lyon said. The vaccines do not affect fertility at all. That misinformation makes it very important to have a connection with a provider you trust.

Because pregnant women were not initially part of the vaccine trials, the CDC and other national organizations advised people to consult their providers and make an informed decision regarding COVID-19 shots. Since then, the accumulated data shows that it is indeed safe for those who are pregnant, wanting to become pregnant or breastfeeding.

As a result, the messaging from the CDC and others has become more urgent.

Peoples initial anxiety about the safety of the vaccine in pregnancy was well-founded, said Dr. Lyon Since then weve had more than 139,000 pregnant women get the vaccine and weve collected data showing no increase in adverse outcomes, no increase in adverse fetal or neonatal outcomes and no increase in adverse maternal outcomes.

The CDC and its federal partners continue to monitor vaccinated people for serious side effects. A CDC analysis of current data from the v-safe pregnancy registry did not find an increased risk of miscarriage among nearly 2,500 pregnant women who received an mRNA COVID-19 vaccine before 20 weeks of pregnancy.

Miscarriage typically occurs in about 11% to 16% of pregnancies, and this study found miscarriage rates after receiving a COVID-19 vaccine were around 13%, similar to the expected rate of miscarriage in the general population.

When we think about the vaccine and how it works, theres no reason it should be unsafe in pregnancy, Dr. Lyon said. There are some vaccines we dont give in pregnancy because theyre a live virus vaccine or they pose a threat to the mom or baby. Thats just not the case with this vaccine.

Fortunately, the updated CDC guideline gives providers another tool in the quest to present accurate information. Given that so many remain wary of a proven safe method to help avoid the virus, physicians will take any help they can get in encouraging vaccination.

Its a hard conversation to have when people are reluctant, Dr. Lyon said. My hope is that because they trust me to provide the best possible prenatal and intrapartum care, they will trust that I have their best interests at heart when I make a recommendation about the vaccine.

Important to remember:

Sanford Health recommends all patients 12 years and older be vaccinated, including those who are pregnant, planning to become pregnant, or breastfeeding. Sanford has also mandated this vaccination to every one of its nearly 50,000 employees.

The CDC recommends COVID-19 vaccinations for all people 12 years and older, including women who are pregnant, breastfeeding or trying to get pregnant now or in the future.

The Society for Maternal-Fetal Medicine (SMFM), American Society for Reproductive Medicine (ASRM) and American College of Obstetricians and Gynecologists (ACOG) all recommend that those who are pregnant should be vaccinated against COVID-19.

Pregnant women with COVID-19 are three times more likely to need ICU care than women who are not pregnant and are two to three times more likely to need advanced life support and a breathing tube.

To schedule your vaccination appointment at Sanford Worthington Clinic, call 372-3800.

Read more here:

Pregnant or breastfeeding? CDC says to get COVID-19 vaccine | The Globe - The Globe

Rockets achieve 100% COVID-19 vaccination rate for 2021-22 roster – Rockets Wire

September 27, 2021

All of the 20 players on the 2021-22 training camp roster for the Rockets have fully completed their COVID-19 vaccinations, Houston general manager Rafael Stone said at Mondays team media day.

For the NBA as a whole, previous reports have pegged the vaccination coverage among players at approximately 90 percent. While the league isnt mandating the vaccine, it is encouraged, and restrictions are significantly reduced for players who are vaccinated.

From a basketball perspective, the biggest competitive benefit is that NBA players who are fully vaccinated will not be subject to regular COVID-19 tests this season, according to reports. As a result, it is much less likely for vaccinated players to miss time while in the leagues health and safety protocols, which caused significant roster disruptions last season for the Rockets and all teams across the league.

NBA players including Washingtons Bradley Beal, Golden States Andrew Wiggins, and Orlandos Jonathan Isaac are among those in recent days who have indicated a reluctance to take the vaccine. But according to Stone, Houston isnt expecting to have any such problems.

Visit link:

Rockets achieve 100% COVID-19 vaccination rate for 2021-22 roster - Rockets Wire

Novavax and the Changing Covid-19 Vaccine Game – InvestorPlace

September 27, 2021

The last time I looked at Novavax (NASDAQ:NVAX) stock, I concluded that finishing third in the Covid-19 vaccine race may be good enough.

Source: Ascannio/Shutterstock.com

It has been quite good for Novavax shareholders. The stock is up 120% in 2021. Thats less than half the gain of rivals BionTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA), but theyve both gotten Covid-19 vaccines approved and into production.

Novavax is still working on it.

Novavax isnt really third, either. Johnson & Johnson (NYSE:JNJ) has had its vaccine out for months. AstraZeneca (NYSE:AZN) has a vaccine. There have been five Chinese vaccines and lots more are on the way.

But Novavax has a cunning plan that could still make it a big winner.

The new game starts with the World Health Organization. It badly wants cheap, effective Covid-19 vaccines delivered around the world, yesterday.

Novavax filed for an emergency approval from WHO on its Covid-19 vaccine. This is an end-run around western agencies that have yet to approve it.

The best vaccines, in terms of efficacy, seem to be those based on messenger RNA (mRNA) technology. Novavax is a protein-based vaccine, along with an adjuvant meant to increase its effectiveness. But our Louis Navellier still thinks Novavax can be a winner in this race. Thats because Novavax compound doesnt require cold storage, like mRNA vaccines.

Novavax is working closely with groups like the Gavi vaccine alliance, which are focused on pooled procurement and equitable distribution. It has an agreement to produce its vaccine in India, and a manufacturing agreement in South Korea.

Manufacturing remains the big if. Novavax says it has production agreements for 2 billion shots next year. But so far, its only production is for clinical trials.

The good news is that if you got a Novavax vaccine in its U.S. trial, youre now considered fully vaccinated. The bad news is that Novavax is still in the process of applying for an emergency use authorization (EUA), which would open the U.S. market.

Novavax also has a flu vaccine in development, called NanoFlu. This failed in previous Phase 3 trials. But it seems to have succeeded in meeting primary endpoints in its latest trial.

This let Novavax begin work on a combined COVID-influenza vaccine, one that would be shelf stable and easily tolerated.

Novavax says its now up to policymakers, not corporations, to drive the use of vaccines. While it opposes a waiver on patents, Novavax work is aimed at making it the low price leader on safe, effective, combination vaccines for a global market.

If Novavax can manufacture its vaccine in quantity, its projecting 2022 revenue of $5.23 billion, with net income of $30.21 per share. That would make the current price of $232 look cheap. The stock would be trading at just 3.6x forward revenue and 8.5x forward earnings.

There remain big ifs around NVAX stock.

If it can scale production, and if it can get approval, and if it can combine its flu vaccine with the Covid-19, Novavax could be a home run for investors in 2022.

Novavax has been hiring experienced pharmaceutical executives, in hopes of getting across the finish line and proving its case to investors.

But there remain uncertainties in the Novavax story. The success of Pfizer (NYSE:PFE), Moderna and BionTech is certain. If youre buying NVAX stock today, youre speculating. At this point in the Covid-19 race thats the best route to fat profits. But its also the riskier play.

On the date of publication, Dana Blankenhorn held long positions in MRNA. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.comPublishing Guidelines.

Dana Blankenhorn has been a financial and technology journalist since 1978. He is the author of Living With Moores Law: Past, Present and Future available at the Amazon Kindle store. Write him at danablankenhorn@gmail.com or tweet him at @danablankenhorn. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

Read more from the original source:

Novavax and the Changing Covid-19 Vaccine Game - InvestorPlace

Some in Raleigh decide to get COVID-19 vaccine booster shot now that its widely available – CBS17.com

September 27, 2021

RALEIGH, N.C. (WNCN) Pfizers COVID-19 booster shots are now widely available for certain people who are at high risk for the virus.

Without hesitation, Ellis Hankins signed up to get his booster shot Sunday at Walgreens.

I got it because the CDC recommends it for people my age. Im in that elderly group, not much, but in it. And I care about my own health and the health of my family and everyone else, Hankins said of why he wanted the booster.

He added, I believe in sound science and they [The CDC] are practicing sound science. So Im taking their recommendation.

Pfizers COVID-19 booster shot is only available to people who have received the first two doses of the Pfizer vaccine. The CDC recommends the booster for people who are 65+ or who are ages 18 to 64 with underlying medical conditions.

Adults living in long-term care facilities or who are frontline workers or in high-risk settings are also eligible for the booster.

I got it just to be better protected. I got up at 5 a.m. on Saturday to make my reservation, said John Griffith, who also got his booster shot on Sunday.

Most people told CBS 17 booking a booster appointment was easy, but when 66-year-old Frederick McDuffey walked into the Walgreens in the Village District, he says he got turned away.

I shop at this store often and I asked the pharmacist back there when could I be eligible for a booster shot because Im 65 and older and she said that they havent got the OK yet and they should have it by next week, said McDuffey. They told me to come back next week either online or I could walk in.

When CBS 17 called Walgreens, someone on the staff confirmed boosters were widely available. Its unclear why McDuffey was told to come back another day.

McDuffey says he plans on trying again Monday.

Reginald McNeil tells CBS 17 hes ready for a booster shot but wants to wait until he asks his doctor about it first. The soon-to-be 54-year-old says hell do anything to celebrate another birthday.

Any means necessary to keep me going, McNeil said of getting a booster shot. Im willing to take that next step.

If you have questions about Pfizer COVID-19 boosters, you can join NCDHHSs upcoming Town Hall featuring Dr. Elizabeth Cuervo Tilson, State Health Director and NCDHHS Chief Medical Officer on Monday, Sept. 27, from 5:30 p.m. to 6 p.m. by dialing (855) 756-7520 and entering 76072# when prompted.

See the original post here:

Some in Raleigh decide to get COVID-19 vaccine booster shot now that its widely available - CBS17.com

Study Examines Herpes Zoster Reactivation Following COVID-19 Vaccination – Pharmacy Times

September 27, 2021

A new study examined 3 different cases of chronic urticaria being treated with cyclosporine and patients who developed reactivation of recurrent herpes zoster (HZ) following COVID-19 vaccination.

A new study examined 3 different cases of chronic urticaria being treated with cyclosporine and patients who developed reactivation of recurrent herpes zoster (HZ) following COVID-19 vaccination.

Each patient developed HZ within a week of receiving the first dose of the COVID-19 vaccine and had a case of chronic spontaneous urticaria being treated with capsule cyclosporine for at least 1 month. Thoracic dermatomes were involved in 2 patients, whereas 1 patient had cervical dermatomal involvement. Further, all 3 patients had developed similar lesions consistent with HZ in the past, according to the study, which was published in the Journal of Cosmetic Dermatology.

Case 1 analyzed a 34-year-old male who experienced a similar episode of HZ 7 months prior over the same site. The examination showed the presence of necrotic ulceration confined to the right T1-T2 dermatome. The lesions had turned into painful stabbing pain 7 days after vaccination and caused erosion and ulceration in the surrounding skin.

In case 2, a 57-year-old male had HZ opthalmicus with painful vesicular eruptions and purulent discharge from the right eye with intense swelling of unilateral eyelid. The previous HZ episode happened 5 years previously on the right side of the thorax.

In case 3, a 38-year-old male had HZ of the T4-T5 dermatomes, which had erupted 4 days following immunization. This patient was already being treated for residual post-herpetic neuralgia, which had developed from an episode of HZ involving the left thorax that occurred 1 year prior.

The patients were treated with T. Valacyclovir 1gm TDS for 7 to 10 days, along with Cap pregabalin and nortriptyline or carbamazepine followed by complete recovery in skin lesions, and all 3 had a negative serological profile for any acquired immunosuppression. Cases 1 and 2 were given tablet prednisolone 60 mg in tapering dose for over 14 days, with the drug being used to treat different inflammation and nerves that would occur from the tablet, according to the study authors.

Cases 2 and 3 failed to show any persistent response with a high dose of antihistaminics and steroids, whereas case 1 had received autologous serum therapy with little to no improvement. The duration of consumption of cyclosporine in our cases prior to onset of RHZ ranged from 5 to 8 weeks. In all 3 cases, the symptoms of HZ were mild to moderate with complete resolution of the condition within a month.

This most recent observation in these 3 cases is contrasting to the recent research that states HZ recurrence to be more common in elderly patients. According to the study authors, this is the first case series of recurrent varicella-zoster virus following COVID-19 vaccination with a strong clinical suspicion of iatrogenic immunosuppression due to cyclosporine. Larger case studies over longer periods of time are recommended for any future studies involving this subject.

REFERENCE

Arora A, Mehta RD, Mohta A, Srinivasa R. Recurrent herpers zoster after COVID-19 vaccination in patients with chronic urticara being treated with cyclosporine- a report of 3 cases. Journal of Cosmetic Dermatology. September 12, 2021. Accessed September 24, 2021.https://doi.org/10.1111/jocd.14437

Read the original:

Study Examines Herpes Zoster Reactivation Following COVID-19 Vaccination - Pharmacy Times

Page 347«..1020..346347348349..360370..»